<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="alzheimer" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">alzheimer</book-part-id>
      <title-group>
        <title>Alzheimer Disease Overview</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bird</surname>
            <given-names>Thomas D</given-names>
          </name>
          <degrees>MD</degrees>
          <email>tomnroz@u.washington.edu</email>
          <aff>Seattle VA Medical Center<break/>Departments of Neurology and Medicine<break/>University of Washington<break/>Seattle, Washington</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="1998-10-23" date-type="created">
          <day>23</day>
          <month>10</month>
          <year>1998</year>
        </date>
        <date iso-8601-date="2010-03-30" date-type="updated">
          <day>30</day>
          <month>3</month>
          <year>2010</year>
        </date>
        <date iso-8601-date="2015-09-24" date-type="revised">
          <day>24</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="alstrom" document-type="chapter">Alstr&#x000f6;m Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="amish-mcph" document-type="chapter">Amish Lethal Microcephaly</related-object>
      <abstract id="alzheimer.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Alzheimer disease (AD) is characterized by dementia that typically begins with subtle and poorly recognized failure of memory and slowly becomes more severe and, eventually, incapacitating. Other common findings include confusion, poor judgment, language disturbance, agitation, withdrawal, and hallucinations. Occasionally, seizures, Parkinsonian features, increased muscle tone, myoclonus, incontinence, and mutism occur. Death usually results from general inanition, malnutrition, and pneumonia. The typical clinical duration of the disease is eight to ten years, with a range from one to 25 years. Approximately 25% of all AD is familial (i.e., &#x02265;2 persons in a family have AD) of which approximately 95% is late onset (age &#x0003e;60-65 years) and 5% is early onset (age &#x0003c;65 years).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Establishing the diagnosis of Alzheimer disease relies on clinical-neuropathologic assessment. Neuropathologic findings of &#x003b2;-amyloid plaques and intraneuronal neurofibrillary tangles remain the gold standard for diagnosis. The clinical diagnosis of AD, based on signs of slowly progressive dementia and findings of gross cerebral cortical atrophy on neuroimaging, is correct approximately 80%-90% of the time. The association of the <italic toggle="yes">APOE</italic> e4 allele with AD is significant; however, <italic toggle="yes">APOE</italic> genotyping is neither fully specific nor sensitive. While <italic toggle="yes">APOE</italic> genotyping may have an adjunct role in the diagnosis of AD in symptomatic individuals, it appears to have little role at this time in predictive testing of asymptomatic individuals. Three forms of early-onset familial AD (EOFAD) &#x02013; caused by mutation of one of three genes <italic toggle="yes">(APP</italic>, <italic toggle="yes">PSEN1</italic>, <italic toggle="yes">PSEN2</italic>) &#x02013; are recognized.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Because AD is genetically heterogeneous, genetic counseling of persons with AD and their family members must be tailored to the information available for that family. It should be pointed out that AD is common and that the overall lifetime risk for any individual of developing dementia is approximately 10%-12%. Genetic counseling for people with non-familial AD and their family members must be empiric and relatively nonspecific. First-degree relatives of a simplex case of AD (i.e., single occurrence in a family) have a cumulative lifetime risk of developing AD of approximately 15%-30%, which is typically reported as a 20%-25% risk. This risk is approximately 2.5 times that of the background risk (~27% vs 10.4%). In contrast, early-onset familial Alzheimer disease (EOFAD) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is supportive; each symptom is managed on an individual basis; assisted living arrangements or care in a nursing home is usually necessary; drugs that increase cholinergic activity by inhibiting acetylcholinesterase produce a modest but useful behavioral or cognitive benefit in a minority of affected individuals (e.g., donepezil [Aricept<sup>&#x000ae;</sup>], rivastigmine [Exelon<sup>&#x000ae;</sup>], galantamine). Memantine, an NMDA receptor antagonist, is also used. Antidepressant medication may improve associated depression.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="alzheimer.Definition">
        <title>Definition</title>
        <sec id="alzheimer.Clinical_Manifestations_of_Alz">
          <title>Clinical Manifestations of Alzheimer Disease</title>
          <p>The clinical manifestation of Alzheimer disease (AD) is dementia that typically begins with subtle and poorly recognized failure of memory and slowly becomes more severe and, eventually, incapacitating. Other common findings include confusion, poor judgment, language disturbance, agitation, withdrawal, and hallucinations. <xref ref-type="bibr" rid="alzheimer.REF.bacanu.2005.624">Bacanu et al [2005]</xref> have shown evidence for heritability of psychotic features in AD (delusions and hallucinations).</p>
          <p>Occasionally, seizures, Parkinsonian features, increased muscle tone, myoclonus, incontinence, and mutism occur [<xref ref-type="bibr" rid="alzheimer.REF.bird.2008">Bird &#x00026; Miller 2008</xref>].</p>
          <p>Death usually results from general inanition, malnutrition, and pneumonia. The typical clinical duration of the disease is eight to ten years, with a range of from one to 25 years.</p>
        </sec>
        <sec id="alzheimer.Establishing_the_Diagnosis_of">
          <title>Establishing the Diagnosis of Alzheimer Disease</title>
          <p>Establishing the diagnosis of Alzheimer disease relies on clinical-neuropathologic assessment. Neuropathologic findings on autopsy examination remain the gold standard for diagnosis of AD. The clinical diagnosis of AD (prior to autopsy confirmation) is correct approximately 80%-90% of the time [<xref ref-type="bibr" rid="alzheimer.REF.mayeux.1998.506">Mayeux et al 1998</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Clinical signs.</bold> Slowly progressive dementia</p>
            </list-item>
            <list-item>
              <p>
                <bold>Neuroimaging</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Gross cerebral cortical atrophy on CT or MRI</p>
                </list-item>
                <list-item>
                  <p>Diffuse cerebral hypometabolism on PET</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Neuropathologic findings.</bold> Microscopic &#x003b2;-amyloid neuritic plaques, intraneuronal neurofibrillary tangles (containing tau protein), and amyloid angiopathy at postmortem examination. The plaques should stain positively with &#x003b2;-amyloid antibodies and negative for prion antibodies, which are diagnostic of <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">prion diseases</related-object>. The numbers of plaques and tangles must exceed those found in age-matched controls without dementia. Guidelines for the quantitative assessment of these changes exist [<xref ref-type="bibr" rid="alzheimer.REF.braak.1991.239">Braak &#x00026; Braak 1991</xref>, <xref ref-type="bibr" rid="alzheimer.REF.national_institute_on_agingreagan_working_group.1997.s1">National Institute on Aging-Reagan Working Group 1997</xref>]. Aggregation of alpha-synuclein in the form of Lewy bodies may also be found in neurons in the amygdala [<xref ref-type="bibr" rid="alzheimer.REF.popescu.2004.1915">Popescu et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Cerebrospinal fluid (CSF).</bold> Decreased A&#x003b2; amyloid 42 and increased tau [<xref ref-type="bibr" rid="alzheimer.REF.snider.2009.638">Snider et al 2009</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer.Differential_Diagnosis_of_Alzh">
          <title>Differential Diagnosis of Alzheimer Disease</title>
          <p>Differential diagnosis of Alzheimer disease includes other causes of dementia, especially treatable forms of cognitive decline including depression, chronic drug intoxication, chronic CNS infection, thyroid disease, vitamin deficiencies (especially B12 and thiamine), CNS angitis, and normal-pressure hydrocephalus [<xref ref-type="bibr" rid="alzheimer.REF.bird.2008">Bird &#x00026; Miller 2008</xref>].</p>
          <p>Other degenerative disorders associated with dementia, such as frontotemporal dementia (including <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter">frontotemporal dementia with parkinsonism-17</related-object>; FTDP-17), Picks disease, <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson disease</related-object>, diffuse Lewy body disease (LBD), <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">Creutzfeldt-Jakob disease</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>, may also be confused with AD [<xref ref-type="bibr" rid="alzheimer.REF.rogan.2002.11">Rogan &#x00026; Lippa 2002</xref>].</p>
          <p>CT and MRI are valuable for identifying some of these other causes of dementia, including neoplasms, normal-pressure hydrocephalus, and cerebral vascular disease.</p>
        </sec>
        <sec id="alzheimer.Prevalence_of_Alzheimer_Diseas">
          <title>Prevalence of Alzheimer Disease</title>
          <p>AD is the most common cause of dementia in North America and Europe, with an estimate of four million affected individuals in the US.</p>
          <p>The prevalence of AD increases with age:</p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 10% of persons over age 70 years have significant memory loss and more than half of these individuals have AD.</p>
            </list-item>
            <list-item>
              <p>An estimated 25%-45% of persons over age 85 years have dementia.</p>
            </list-item>
          </list>
          <p>The incidence of AD rises from 2.8 per 1,000 person years in the 65-69 year age group to 56.1 per 1,000 person years in the older than 90 year age group [<xref ref-type="bibr" rid="alzheimer.REF.kukull.2002.1737">Kukull et al 2002</xref>].</p>
        </sec>
      </sec>
      <sec id="alzheimer.Causes">
        <title>Causes</title>
        <table-wrap id="alzheimer.T.causes_of_alzheimer_disease" position="anchor" orientation="portrait">
          <label>Table 1. </label>
          <caption>
            <p>Causes of Alzheimer Disease</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cause</th>
                <th id="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of Cases</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Chromosomal (Down syndrome)</td>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
              </tr>
              <tr>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">All familial</td>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~25%</td>
              </tr>
              <tr>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Late-onset familial (AD2)</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%-25%</td>
              </tr>
              <tr>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p><related-object link-type="booklink" source-id="gene" document-id="alzheimer-early" document-type="chapter">Early-onset familial AD</related-object> (AD1, AD3, AD4)</p>
                    </list-item>
                  </list>
                </td>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;2%</td>
              </tr>
              <tr>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown (includes genetic/environment interactions)</td>
                <td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~75%</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Approximately 1%-6% of all Alzheimer disease (AD) is early onset (age &#x0003c;60-65 years) and approximately 60% of early-onset AD is familial, with 13% appearing to be inherited in an autosomal dominant manner [<xref ref-type="bibr" rid="alzheimer.REF.campion.1999.664">Campion et al 1999</xref>].</p>
        <p>The distinction between early-onset familial Alzheimer disease (onset age &#x0003c;60-65 years) and late-onset familial Alzheimer disease (onset age &#x0003e;60-65 years) is somewhat arbitrary. Note: Early-onset cases can occur in families with generally late-onset disease [<xref ref-type="bibr" rid="alzheimer.REF.brickell.2006.1307">Brickell et al 2006</xref>].</p>
        <sec id="alzheimer.Environmental_Causes">
          <title>Environmental Causes</title>
          <p>No environmental agents (e.g., viruses, toxins) have been proven to be directly involved in the pathogenesis of AD. It is often speculated that late-onset AD is the result of unknown environmental factors acting on a predisposing genetic background [<xref ref-type="bibr" rid="alzheimer.REF.borenstein.2006.63">Borenstein et al 2006</xref>]. Twin studies have implicated both genes and environment [<xref ref-type="bibr" rid="alzheimer.REF.gatz.2006.168">Gatz et al 2006</xref>]. Repeated head trauma has been associated with dementia having excessive neurofibrillary tangle formation [<xref ref-type="bibr" rid="alzheimer.REF.mckee.2009.709">McKee et al 2009</xref>].</p>
        </sec>
        <sec id="alzheimer.Heritable_Causes">
          <title>Heritable Causes</title>
          <sec id="alzheimer.Chromosomal">
            <title>Chromosomal</title>
            <p><bold>Down syndrome (DS).</bold> Essentially all persons with Down syndrome (trisomy 21) develop the neuropathologic hallmarks of AD after age 40 years. If carefully observed or tested, more than half of individuals with DS also show clinical evidence of cognitive decline. The presumed reason for this association is the lifelong over-expression of <italic toggle="yes">APP</italic> on chromosome 21 encoding the amyloid precursor protein and the resultant overproduction of &#x003b2;-amyloid in the brains of persons who are trisomic for this gene.</p>
            <p>The amyloid-&#x003b2; (A&#x003b2;) deposition in the brain may begin in the first decade of life in persons with DS [<xref ref-type="bibr" rid="alzheimer.REF.leverenz.1998.296">Leverenz &#x00026; Raskind 1998</xref>]. AD was not noted clinically or pathologically in a 78-year-old woman with partial trisomy 21 who did not have an extra copy of <italic toggle="yes">APP</italic> [<xref ref-type="bibr" rid="alzheimer.REF.prasher.1998.380">Prasher et al 1998</xref>]. Two studies have found no association of <italic toggle="yes">APOE</italic> genotype with age of onset of dementia in Down syndrome [<xref ref-type="bibr" rid="alzheimer.REF.lai.1999.331">Lai et al 1999</xref>, <xref ref-type="bibr" rid="alzheimer.REF.margallolana.2004.1996">Margallo-Lana et al 2004</xref>], but one study did find an association of onset age with a polymorphism in <italic toggle="yes">APP</italic> [<xref ref-type="bibr" rid="alzheimer.REF.margallolana.2004.1996">Margallo-Lana et al 2004</xref>].</p>
            <p><xref ref-type="bibr" rid="alzheimer.REF.schupf.2001.979">Schupf et al [2001]</xref> found an unexplained increased risk for AD in mothers who gave birth to children with DS prior to age 35 years.</p>
          </sec>
          <sec id="alzheimer.Single_Gene">
            <title>Single Gene</title>
            <p>Approximately 25% of AD is familial (i.e., two or more family members have AD). Familial cases appear to have the same clinical and pathologic phenotypes as non-familial cases (i.e., an individual with AD and no known family history of AD) [<xref ref-type="bibr" rid="alzheimer.REF.nochlin.1993.212">Nochlin et al 1993</xref>] and are thus distinguished only by family history or by molecular genetic testing. A large volume of research on the molecular and genetic basis of AD has been summarized by <xref ref-type="bibr" rid="alzheimer.REF.rosenberg.2000.2045">Rosenberg [2000]</xref>, <xref ref-type="bibr" rid="alzheimer.REF.sleegers.2001.197">Sleegers &#x00026; Van Duijn [2001]</xref>, <xref ref-type="bibr" rid="alzheimer.REF.nussbaum.2003.1356">Nussbaum &#x00026; Ellis [2003]</xref>, <xref ref-type="bibr" rid="alzheimer.REF.goedert.2006.777">Goedert &#x00026; Spillantini [2006]</xref>, and <xref ref-type="bibr" rid="alzheimer.REF.roses.2006.59">Roses &#x00026; Saunders [2006]</xref>.</p>
            <p><bold>Late-onset familial AD (AD2)</bold> (see <xref ref-type="table" rid="alzheimer.T.lateonset_familial_alzheimer">Table 2</xref>)</p>
            <p><bold>Molecular genetics.</bold> Investigations have supported the concept that late-onset AD is a complex disorder that may involve multiple susceptibility genes (reviewed and summarized by <xref ref-type="bibr" rid="alzheimer.REF.van_cauwenberghe.2015">Van Cauwenberghe et al [2015]</xref>).</p>
            <p>The association of late-onset familial AD (FAD) with the <italic toggle="yes">APOE</italic> e4 allele is well documented. The <italic toggle="yes">APOE</italic> e4 allele, by unknown mechanisms, appears to affect age of onset by shifting the onset toward an earlier age [<xref ref-type="bibr" rid="alzheimer.REF.khachaturian.2004.518">Khachaturian et al 2004</xref>].</p>
            <table-wrap id="alzheimer.T.lateonset_familial_alzheimer" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p>Late-Onset Familial Alzheimer Disease: Molecular Genetics</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Locus Name</th>
                    <th id="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                    <th id="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AD2</td>
                    <td headers="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                      <italic toggle="yes">APOE</italic>
                    </td>
                    <td headers="hd_h_alzheimer.T.lateonset_familial_alzheimer_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Apolipoprotein E</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p>Other genes of interest in FAD:</p>
            <list list-type="bullet">
              <list-item>
                <p><xref ref-type="bibr" rid="alzheimer.REF.jonsson.2013.107">Jonsson et al [2013]</xref> and <xref ref-type="bibr" rid="alzheimer.REF.guerreiro.2013.117">Guerreiro et al [2013]</xref> have identified the p.Arg47His allelic variant in <italic toggle="yes">TREM2</italic> as a statistically significant risk factor for late-onset AD. Although this variant in the heterozygous state is rare in the general population (0.5%-1%) it results in an odds ratio of about 3.0 for the occurrence of AD. <xref ref-type="bibr" rid="alzheimer.REF.korvatska.2015.920">Korvatska et al [2015]</xref> show how this variant can likely interact with the <italic toggle="yes">APOE</italic> e4 allele to increase the risk for AD in a large family. Homozygous or compound heterozygous variants in <italic toggle="yes">TREM2</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="plosl" document-type="chapter">PLOSL</related-object>, a rare disease causing bone fractures and early-onset dementia with leukodystrophy.</p>
              </list-item>
              <list-item>
                <p><xref ref-type="bibr" rid="alzheimer.REF.delaguila.2015.49">Del-Aguila et al [2015]</xref> discuss variants in <italic toggle="yes">TREM2</italic>, <italic toggle="yes">PLD3</italic>, <italic toggle="yes">UNC5C</italic>, and <italic toggle="yes">AKAP9</italic> (in African Americans only) that are &#x0201c;rare&#x0201d; (&#x02264;1%) in the general population but have an increased association with AD (so called rare variants with large effect sizes).</p>
              </list-item>
              <list-item>
                <p>Potential protective mutation of <italic toggle="yes">APP</italic>. <xref ref-type="bibr" rid="alzheimer.REF.jonsson.2012.96">Jonsson et al [2012]</xref> have reported an allelic variant in <italic toggle="yes">APP</italic> that appears to protect against the occurrence of AD. The variant (p.Ala673Thr) has a frequency of about 0.6%-0.7% in the non-dementia control population in northern Europe and about 0.13% in an AD population (OR 5.29). This variant occurs at the site where BACE1 cleaves APP to form the &#x003b2;-amyloid peptide and also where a recessive pathogenic variant (p.Ala673Val) causing early-onset AD has been reported [<xref ref-type="bibr" rid="alzheimer.REF.di_fede.2009.1473">Di Fede et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p>Although the many genetic associations found with GWAS studies appear almost random and confusing, the <xref ref-type="bibr" rid="alzheimer.REF.international_genomics_of_alzheimers_disease_consortium.2015.658">International Genomics of Alzheimer's Disease Consortium [2015]</xref> have analyzed the data and note that the AD-related genes tend to occur in biologically plausible pathways for pathogenesis (e.g., immune response, regulation of endocytosis, cholesterol transport, protein ubiquitination).</p>
              </list-item>
            </list>
            <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="alzheimer-additional_genes.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for information on genes of research interest.</p>
            <p><bold>Clinical features.</bold> Many families have multiple affected members, most or all of whom have onset of dementia after age 60 or 65 years. Disease duration is typically eight to ten years, but ranges from two to 25 years.</p>
            <p>
              <bold>Early-onset familial AD (EOFAD)</bold>
            </p>
            <p><bold>Molecular genetics.</bold> At least three subtypes of EOFAD (AD1, AD3, AD4) have been identified based on the gene in which mutation is causative. The relative proportion of each subtype and the related genes are summarized in <xref ref-type="table" rid="alzheimer.T.earlyonset_familial_alzheime">Table 3</xref> [<xref ref-type="bibr" rid="alzheimer.REF.campion.1999.664">Campion et al 1999</xref>, <xref ref-type="bibr" rid="alzheimer.REF.janssen.2003.235">Janssen et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer.REF.raux.2005.793">Raux et al 2005</xref>]. See also <related-object link-type="booklink" source-id="gene" document-id="alzheimer-early" document-type="chapter">Early-Onset Familial Alzheimer Disease</related-object>. It is likely that mutation in other genes will be identified as causative of EOFAD because kindreds with autosomal dominant FAD with no known pathogenic variants in <italic toggle="yes">PSEN1</italic>, <italic toggle="yes">PSEN2</italic>, or <italic toggle="yes">APP</italic> have been described [<xref ref-type="bibr" rid="alzheimer.REF.raux.2005.793">Raux et al 2005</xref>].</p>
            <table-wrap id="alzheimer.T.earlyonset_familial_alzheime" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p>Early-Onset Familial Alzheimer Disease (EOFAD): Molecular Genetics</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Locus Name</th>
                    <th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of EOFAD</th>
                    <th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                    <th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AD3</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%-70%</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <italic toggle="yes">PSEN1</italic>
                    </td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Presenilin-1</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AD1</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10%-15%</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <italic toggle="yes">APP</italic>
                    </td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Amyloid beta A4 protein</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">AD4</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <italic toggle="yes">PSEN2</italic>
                    </td>
                    <td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Presenilin-2</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <p><bold>Clinical features.</bold> Early-onset familial AD refers to families in which multiple cases of AD occur with the mean age of onset usually before age 65 years, although some studies have used age 60 years or 70 years. Age of onset is usually in the 40s or early 50s, although onset in the 30s and early 60s has been reported. <xref ref-type="bibr" rid="alzheimer.REF.campion.1999.664">Campion et al [1999]</xref> found a prevalence of early-onset AD in the general population of 41.2 per 100,000 persons at risk (ages 40-59 years). Sixty-one percent of these individuals with early-onset AD had a positive family history and 13% met stringent criteria for autosomal dominant inheritance (i.e., affected individuals in 3 generations).</p>
            <p>EOFAD cannot be clinically distinguished from non-familial AD except on the basis of family history and age of onset. The dementia phenotype is similar to that of late-onset AD, sometimes with a long prodrome [<xref ref-type="bibr" rid="alzheimer.REF.godbolt.2004.1743">Godbolt et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer.REF.larner.2006.139">Larner &#x00026; Doran 2006</xref>].</p>
          </sec>
        </sec>
        <sec id="alzheimer.Unknown_Causes">
          <title>Unknown Causes</title>
          <p>Individuals with non-familial AD meet the diagnostic criteria for AD and have a negative family history. Onset can be anytime in adulthood. The exact pathogenesis of the disease is unknown. A common hypothesis is that non-familial AD is multifactorial and results from a combination of aging, genetic predisposition, and exposure to one or more environmental agents including head trauma, low education level, viruses, and/or toxins, although no environmental agents have been proven to be directly involved in the pathogenesis of AD.</p>
        </sec>
      </sec>
      <sec id="alzheimer.Evaluation_Strategy">
        <title>Evaluation Strategy</title>
        <sec id="alzheimer.Family_History">
          <title>Family History</title>
          <p>A three-generation family history with close attention to the history of individuals with dementia should be obtained. For each affected individual, the age of onset of dementia should be noted. Generally, individuals with onset before age 65 years are considered to have early-onset Alzheimer disease (AD) and those with onset after age 65 years are considered to have late-onset AD. Medical records of affected family members, including reports of neuroimaging studies and autopsy examinations, should be obtained:</p>
          <list list-type="bullet">
            <list-item>
              <p>The diagnosis of EOFAD is made in families with multiple cases of AD in which the mean age of onset is before age 60 to 65 years.</p>
            </list-item>
            <list-item>
              <p>The diagnosis of late-onset FAD is made in families with multiple cases of AD in which the mean age of onset is after age 60 to 65 years.</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Late-onset familial AD.</bold> The association of one or two copies of the <italic toggle="yes">APOE</italic> allele e4 (i.e., genotypes e2/e4, e3/e4, e4/e4) with late-onset Alzheimer disease (AD) is well documented (<xref ref-type="table" rid="alzheimer.T.percent_of_apoe_genotypes_in">Table 4</xref>) [<xref ref-type="bibr" rid="alzheimer.REF.jarvik.1996.191">Jarvik et al 1996</xref>, <xref ref-type="bibr" rid="alzheimer.REF.khachaturian.2004.518">Khachaturian et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer.REF.martins.2005.1888">Martins et al 2005</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>The association between <italic toggle="yes">APOE</italic> e4 and AD is greatest when the individual has a positive family history of dementia. The last column of <xref ref-type="table" rid="alzheimer.T.percent_of_apoe_genotypes_in">Table 4</xref> largely represents late-onset familial AD.</p>
            </list-item>
            <list-item>
              <p>The strongest association between the <italic toggle="yes">APOE</italic> e4 allele and AD, relative to the normal control population, is with the e4/e4 genotype. That genotype occurs in approximately 1% of the normal control population and in nearly 19% of the familial AD population.</p>
            </list-item>
            <list-item>
              <p>In individuals who have the clinical diagnosis of AD, the probability that AD is the correct diagnosis is increased to approximately 97% in the presence of the <italic toggle="yes">APOE</italic> e4/e4 genotype.Note: The increased risk of AD associated with one <italic toggle="yes">APOE</italic> e4 allele or two <italic toggle="yes">APOE</italic> e4 alleles is also found in African-Americans [<xref ref-type="bibr" rid="alzheimer.REF.green.2002.329">Green et al 2002</xref>] and Caribbean Hispanics [<xref ref-type="bibr" rid="alzheimer.REF.romas.2002.87">Romas et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Approximately 42% of persons with AD do <bold>not</bold> have an <italic toggle="yes">APOE</italic> e4 allele. Thus, <italic toggle="yes">APOE</italic> genotyping is not specific for AD. The absence of an <italic toggle="yes">APOE</italic> e4 allele does not rule out the diagnosis of AD [<xref ref-type="bibr" rid="alzheimer.REF.mayeux.1998.506">Mayeux et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="alzheimer.REF.breitner.1999.321">Breitner et al [1999]</xref> have estimated lifetime risks for developing AD based on gender and <italic toggle="yes">APOE</italic> genotype. See <xref ref-type="sec" rid="alzheimer.Genetic_Counseling">Genetic Counseling</xref>, <bold>Testing of at-risk asymptomatic family members</bold>.</p>
            </list-item>
          </list>
          <p>The usefulness of <italic toggle="yes">APOE</italic> genotyping in clinical diagnosis and risk assessment remains unclear [<xref ref-type="sec" rid="alzheimer.References">Published Guidelines/Consensus Statements</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Although the presence of one <italic toggle="yes">APOE</italic> e4 allele or two <italic toggle="yes">APOE</italic> e4 alleles is neither necessary nor sufficient to establish a diagnosis of AD, <italic toggle="yes">APOE</italic> genotyping may have an adjunct role in the diagnosis of AD because a large proportion of individuals with one <italic toggle="yes">APOE</italic> e4 allele or two <italic toggle="yes">APOE</italic> e4 alleles who are demented have been found to have neuropathologic confirmation of AD at autopsy [<xref ref-type="bibr" rid="alzheimer.REF.national_institute_on_agingalzheimer_s_association_working_group.1996.1091">National Institute on Aging-Alzheimer&#x02019;s Association Working Group 1996</xref>, <xref ref-type="bibr" rid="alzheimer.REF.mayeux.1998.506">Mayeux et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>In contrast, <italic toggle="yes">APOE</italic> genotyping was not found to be of significant diagnostic use in identifying AD in a community-based sample with late-onset dementia [<xref ref-type="bibr" rid="alzheimer.REF.tsuang.1999.1489">Tsuang et al 1999</xref>].</p>
            </list-item>
          </list>
          <p>There is some evidence that the <italic toggle="yes">APOE</italic> e2 allele may have a protective effect in regard to risk for AD (<xref ref-type="table" rid="alzheimer.T.percent_of_apoe_genotypes_in">Table 4</xref>).</p>
          <table-wrap id="alzheimer.T.percent_of_apoe_genotypes_in" position="anchor" orientation="portrait">
            <label>Table 4. </label>
            <caption>
              <p>Percent of <italic toggle="yes">APOE</italic> Genotypes in Controls and Individuals with AD</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">APOE</italic> Genotype</th>
                  <th id="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Normal Controls (n=304)</th>
                  <th id="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">All Individuals with AD (n=233)</th>
                  <th id="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Individuals with AD and Positive Family History of Dementia&#x000a0;<sup>1</sup> (n=85)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e2/e2</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1.3%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e2/e3</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12.5%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.4%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">3.5%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e2/e4</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4.9%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4.3%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">8.2%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e3/e3</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">59.9%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">38.2%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">23.5%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e3/e4</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20.7%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">41.2%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">45.9%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e4/e4</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.7%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12.9%</td>
                  <td headers="hd_h_alzheimer.T.percent_of_apoe_genotypes_in_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">18.8%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Modified from <xref ref-type="bibr" rid="alzheimer.REF.jarvik.1996.191">Jarvik et al [1996]</xref></p>
              </fn>
              <fn id="alzheimer.TF.4.1">
                <label>1. </label>
                <p>Most families would be considered to have late-onset familial AD.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Another way to look at this association between AD and an <italic toggle="yes">APOE</italic> e4 allele is with <italic toggle="yes">APOE</italic> e4 allele frequencies (<xref ref-type="table" rid="alzheimer.T.apoe_allele_frequencies_in_c">Table 5</xref>).</p>
          <table-wrap id="alzheimer.T.apoe_allele_frequencies_in_c" position="anchor" orientation="portrait">
            <label>Table 5. </label>
            <caption>
              <p><italic toggle="yes">APOE</italic> Allele Frequencies in Controls and Individuals with AD</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">APOE</italic> Allele</th>
                  <th id="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Normal Controls (n=304)</th>
                  <th id="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">All Individuals with AD (n=233)</th>
                  <th id="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Individuals with AD and Positive Family History of Dementia&#x000a0;<sup>1</sup> (n=85)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e2</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">9.0%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3.9%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">5.9%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e3</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">76.5%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">60.5%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">48.2%</td>
                </tr>
                <tr>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">e4</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">13.7%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">35.6%</td>
                  <td headers="hd_h_alzheimer.T.apoe_allele_frequencies_in_c_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">45.9%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Modified from <xref ref-type="bibr" rid="alzheimer.REF.jarvik.1996.191">Jarvik et al [1996]</xref></p>
              </fn>
              <fn id="alzheimer.TF.5.1">
                <label>1. </label>
                <p>Most families would be considered to have late-onset familial AD.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Early-onset familial Alzheimer disease.</bold> The three known subtypes of EOFAD, called AD3, AD1, and AD4 [<xref ref-type="bibr" rid="alzheimer.REF.tsuang.1999.1489">Tsuang et al 1999</xref>] can only be distinguished by molecular genetic testing (<xref ref-type="table" rid="alzheimer.T.earlyonset_familial_alzheime">Table 3</xref>). (See <related-object link-type="booklink" source-id="gene" document-id="alzheimer-early" document-type="chapter">Early-Onset Familial Alzheimer Disease</related-object> for details about molecular genetic testing.) Genetic testing of individuals who are simplex cases (i.e., a single occurrence of early-onset AD in a family) is controversial and should be undertaken in the context of formal genetic counseling [<xref ref-type="bibr" rid="alzheimer.REF.van_der_cammen.2004.2110">van der Cammen et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="alzheimer.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="alzheimer.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Because Alzheimer disease (AD) is genetically heterogeneous, genetic counseling of persons with AD and their family members must be tailored to the information available for that family. Early-onset familial Alzheimer disease is inherited in an autosomal dominant manner. AD is considered polygenic and multifactorial.</p>
        </sec>
        <sec id="alzheimer.Risk_to_Family_Members__LateOn">
          <title>Risk to Family Members &#x02014; Late-Onset Non-Familial Alzheimer Disease</title>
          <p>Genetic counseling for people with non-familial AD and their family members must be empiric and relatively nonspecific. It should be pointed out that AD is common and that the overall lifetime risk to any individual of developing dementia is approximately 10%-12%.</p>
          <p>
            <bold>Parents, sibs, and offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>First-degree relatives of a person with AD have a cumulative lifetime risk of developing AD of approximately 15%-30%, which is typically reported as a 20%-25% risk [<xref ref-type="bibr" rid="alzheimer.REF.farrer.1989.485">Farrer et al 1989</xref>, <xref ref-type="bibr" rid="alzheimer.REF.silverman.1994.577">Silverman et al 1994</xref>]. This risk is approximately 2.5 times that of the background risk (~27% vs 10.4%) [<xref ref-type="bibr" rid="alzheimer.REF.green.2002.329">Green et al 2002</xref>, <xref ref-type="bibr" rid="alzheimer.REF.cupples.2004.192">Cupples et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Disagreement exists as to whether the age of onset of the affected person changes the risk to first-degree relatives. One study found that early-onset AD increased the risk [<xref ref-type="bibr" rid="alzheimer.REF.silverman.1994.577">Silverman et al 1994</xref>], while another study did not [<xref ref-type="bibr" rid="alzheimer.REF.farrer.1989.485">Farrer et al 1989</xref>].</p>
            </list-item>
            <list-item>
              <p>The number of additional affected family members probably increases the risk to close relatives, but the magnitude of that increase is unclear unless the pattern in the family is characteristic of autosomal dominant inheritance. Having two, three, or more affected family members probably raises the risk to other first-degree relatives in excess of that noted above for non-familial cases, although the exact magnitude of the risk is not clear. <xref ref-type="bibr" rid="alzheimer.REF.heston.1981.1085">Heston et al [1981]</xref> found a 35%-45% risk of dementia in individuals who had a parent with AD and a sib with onset of AD before age 70 years. <xref ref-type="bibr" rid="alzheimer.REF.jayadev.2008.373">Jayadev et al [2008]</xref> also reported preliminary data suggesting that offspring of parents with conjugal AD (i.e., both parents affected) had an increased risk of dementia.</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer.Risk_to_Family_Members__EarlyO">
          <title>Risk to Family Members &#x02014; Early-Onset Familial Alzheimer Disease</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed as having early-onset Alzheimer disease have another affected family member, although family history is negative 40% of the time [<xref ref-type="bibr" rid="alzheimer.REF.campion.1999.664">Campion et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p>Family history may be "negative" because of early death of a parent, failure to recognize the disorder in family members, or, rarely, a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the proband's parent.</p>
            </list-item>
            <list-item>
              <p>If one of the proband's parents has a mutant allele, the risk to the sibs of inheriting the mutant allele is 50%.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Individuals with early-onset familial Alzheimer disease have a 50% chance of transmitting the mutant allele to each child.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="alzheimer.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Use of <italic toggle="yes">APOE</italic> genotyping for predictive testing.</bold> In contrast to the utility of <italic toggle="yes">APOE</italic> testing as an adjunct diagnostic test in individuals with dementia, there is general agreement that <italic toggle="yes">APOE</italic> testing should be used cautiously for predictive testing for AD in asymptomatic persons. Data suggest that a young asymptomatic person with the <italic toggle="yes">APOE</italic> e4/e4 genotype may have an approximately 30% lifetime risk of developing AD. Further refinement of this risk reveals that females with an <italic toggle="yes">APOE</italic> e4/e4 genotype have a 45% probability of developing AD by age 73 years, whereas males have a 25% risk [<xref ref-type="bibr" rid="alzheimer.REF.breitner.1999.321">Breitner et al 1999</xref>]. These risks are lower &#x02014; and the likely age of onset later &#x02014; for persons with only one <italic toggle="yes">APOE</italic> e4 allele (peak age 87 years) or no <italic toggle="yes">APOE</italic> e4 allele (peak age 95 years). These estimates are not generally considered clinically useful; however, a research study to assess the potential utility of <italic toggle="yes">APOE</italic> testing in relatives of individuals with late-onset AD is under way [<xref ref-type="bibr" rid="alzheimer.REF.green.2002.208">Green 2002</xref>, <xref ref-type="bibr" rid="alzheimer.REF.roberts.2005.250">Roberts et al 2005</xref>, <xref ref-type="bibr" rid="alzheimer.REF.green.2009.245">Green et al 2009</xref>].</p>
          <p><bold>Down syndrome.</bold> Family members of persons with Down syndrome are not at increased risk for AD.</p>
          <p>
            <bold>Testing of at-risk asymptomatic family members</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Testing of at-risk asymptomatic adults.</bold> Testing of asymptomatic adults at risk for early-onset familial Alzheimer disease (EOFAD) caused by pathogenic variants in <italic toggle="yes">PSEN1</italic>, <italic toggle="yes">PSEN2</italic>, or <italic toggle="yes">APP</italic> is possible. Testing results for at-risk asymptomatic adults can only be interpreted after the pathogenic variant has been identified in an affected family member. It should be remembered that testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.Preliminary results have shown that while relatively few family members choose such testing, they usually cope well with the results, which can affect personal relationships and emotional well-being [<xref ref-type="bibr" rid="alzheimer.REF.steinbart.2001.1828">Steinbart et al 2001</xref>]. However, significant depression following such testing has been reported [<xref ref-type="bibr" rid="alzheimer.REF.quaid.2000.327">Quaid et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Testing of at-risk individuals during childhood.</bold> Consensus holds that individuals at risk for adult-onset disorders should not have testing during childhood in the absence of symptoms. The principal arguments against such testing are that it removes their choice to know or not know this information, it raises the possibility of stigmatization within the family and in other social settings, and it could have serious educational and career implications. See also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="alzheimer.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variant has been identified in the family, prenatal diagnosis for pregnancies at increased risk may be available from a laboratory offering either testing of the gene of interest or custom testing.</p>
          <p>Requests for prenatal diagnosis of adult-onset diseases are uncommon. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate [<xref ref-type="bibr" rid="alzheimer.REF.quaid.2000.327">Quaid et al 2000</xref>].</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified. Preimplantation diagnosis has been reported in a mother with an <italic toggle="yes">APP</italic> pathogenic variant [<xref ref-type="bibr" rid="alzheimer.REF.towner.2002.1038">Towner &#x00026; Loewy 2002</xref>, <xref ref-type="bibr" rid="alzheimer.REF.verlinsky.2002.1018">Verlinsky et al 2002</xref>].</p>
        </sec>
      </sec>
      <sec id="alzheimer.Resources">
        <title>Resources</title>
      </sec>
      <sec id="alzheimer.Management">
        <title>Management</title>
        <sec id="alzheimer.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The mainstay of treatment for Alzheimer disease (AD) is necessarily supportive and each symptom is managed on an individual basis [<xref ref-type="bibr" rid="alzheimer.REF.bird.2008">Bird &#x00026; Miller 2008</xref>]. In general, affected individuals eventually require assisted living arrangements or care in a nursing home.</p>
          <p>Although the exact biochemical basis of AD is not well understood, it is known that deficiencies of the brain cholinergic system and of other neurotransmitters are present. Drugs that increase cholinergic activity by inhibiting acetylcholinesterase produce a modest but useful behavioral or cognitive benefit in a minority of affected individuals. The first such drug was tacrine; however, this agent is also hepatotoxic. Newer such drugs with similar pharmacologic action, such as donepezil (Aricept<sup>&#x000ae;</sup>) [<xref ref-type="bibr" rid="alzheimer.REF.feldman.2004.644">Feldman et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer.REF.seltzer.2004.1852">Seltzer et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer.REF.petersen.2005.2379">Petersen et al 2005</xref>], rivastigmine (Exelon<sup>&#x000ae;</sup>) [<xref ref-type="bibr" rid="alzheimer.REF.feldman.2007.1056">Feldman et al 2007</xref>], and galantamine [<xref ref-type="bibr" rid="alzheimer.REF.raskind.2000.2261">Raskind et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer.REF.tariot.2000.2269">Tariot et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer.REF.mega.2005.721">Mega et al 2005</xref>, <xref ref-type="bibr" rid="alzheimer.REF.reisberg.2006.49">Reisberg et al 2006</xref>, <xref ref-type="bibr" rid="alzheimer.REF.atri.2008.209">Atri et al 2008</xref>], are not hepatotoxic.</p>
          <p>Memantine, an NMDA receptor antagonist, has shown some effectiveness in the treatment of moderate to severe AD [<xref ref-type="bibr" rid="alzheimer.REF.reisberg.2003.1333">Reisberg et al 2003</xref>, <xref ref-type="bibr" rid="alzheimer.REF.tariot.2004.317">Tariot et al 2004</xref>].</p>
          <p>Antidepressant medication may improve associated depression.</p>
          <p>Agitation is especially difficult to control [<xref ref-type="bibr" rid="alzheimer.REF.teri.2000.1271">Teri et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer.REF.mintzer.2006.280">Mintzer et al 2006</xref>]</p>
        </sec>
        <sec id="alzheimer.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Treatment trials evaluating use of anti-inflammatory agents (NSAIDs), estrogens, nerve growth factors, ginkgo biloba, statins, BACE inhibitors, and antioxidants are under way or recently reviewed [<xref ref-type="bibr" rid="alzheimer.REF.overshott.2005.v53">Overshott &#x00026; Burns 2005</xref>, <xref ref-type="bibr" rid="alzheimer.REF.klafki.2006.2840">Klafki et al 2006</xref>, <xref ref-type="bibr" rid="alzheimer.REF.masters.2006.2823">Masters &#x00026; Beyreuther 2006</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="alzheimer.Other">
          <title>Other</title>
          <p>Vitamins and other over-the-counter medications have been used in the treatment of AD [<xref ref-type="bibr" rid="alzheimer.REF.yaffe.2004.1705">Yaffe et al 2004</xref>].</p>
          <p>Some, but not all, reports suggest that affected individuals taking HMG-coenzyme A reductase inhibitors for hypercholesteralemia have a reduced incidence of dementia [<xref ref-type="bibr" rid="alzheimer.REF.wolozin.2000.1439">Wolozin et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer.REF.li.2004.1624">Li et al 2004</xref>].</p>
          <p>Immunization of an AD mouse model with &#x003b2;-amyloid has attenuated the AD pathology and stimulated the search for a possible vaccination approach to the treatment of human AD [<xref ref-type="bibr" rid="alzheimer.REF.schenk.1999.173">Schenk et al 1999</xref>]. A human trial of this approach was halted because of encephalitis in a few subjects [<xref ref-type="bibr" rid="alzheimer.REF.check.2002.462">Check 2002</xref>, <xref ref-type="bibr" rid="alzheimer.REF.ferrer.2004.11">Ferrer et al 2004</xref>, <xref ref-type="bibr" rid="alzheimer.REF.holmes.2008.216">Holmes et al 2008</xref>]. Other approaches to this model are under investigation.</p>
          <p>Thus far, treatment of symptomatic AD with estrogens has not proven beneficial [<xref ref-type="bibr" rid="alzheimer.REF.mulnard.2000.1007">Mulnard et al 2000</xref>, <xref ref-type="bibr" rid="alzheimer.REF.wang.2000.2061">Wang et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="alzheimer.References">
        <title>References</title>
        <sec id="alzheimer.Published_GuidelinesConsensus">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="alzheimer.Published_GuidelinesConsensus.reflist0">
            <ref id="alzheimer.REF1">
              <mixed-citation publication-type="webpage">American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's disease. Statement on use of apolipoprotein E testing for Alzheimer's disease. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jama.jamanetwork.com/article.aspx?articleid=391859">online</ext-link>. 1995. Accessed 9-16-15.</mixed-citation>
            </ref>
            <ref id="alzheimer.REF2">
              <mixed-citation publication-type="webpage">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 9-16-15.</mixed-citation>
            </ref>
            <ref id="alzheimer.REF3">
              <mixed-citation publication-type="webpage">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 9-16-15.</mixed-citation>
            </ref>
            <ref id="alzheimer.REF.post.1997.832">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Post</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binstock</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckert</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleck</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaines</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juengst</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlinsky</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaid</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Relkin</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roses</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachs</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbock</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truschke</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinn</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The clinical introduction of genetic testing for Alzheimer's disease: an ethical perspective.</article-title>
                <source>JAMA</source>
                <volume>277</volume>
                <fpage>832</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9052715</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="alzheimer.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="alzheimer.Literature_Cited.reflist0">
            <ref id="alzheimer.REF.atri.2008.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Atri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaughnessy</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locascio</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Growdon</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease.</article-title>
                <source>Alzheimer Dis Assoc Disord</source>
                <volume>22</volume>
                <fpage>209</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18580597</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.bacanu.2005.624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bacanu</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devlin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chowdari</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeKosky</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nimgaonkar</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweet</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Heritability of Psychosis in Alzheimer Disease.</article-title>
                <source>Am J Geriatr Psychiatry</source>
                <volume>13</volume>
                <fpage>624</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16009739</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.bird.2008">
              <mixed-citation publication-type="book">Bird TD, Miller BL. Alzheimer's disease and primary dementias. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 17 ed. New York, NY: McGraw-Hill; 2008:2393-406.</mixed-citation>
            </ref>
            <ref id="alzheimer.REF.borenstein.2006.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borenstein</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copenhaver</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortimer</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Early-life risk factors for Alzheimer disease.</article-title>
                <source>Alzheimer Dis Assoc Disord</source>
                <volume>20</volume>
                <fpage>63</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16493239</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.braak.1991.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Braak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braak</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Neuropathological stageing of Alzheimer-related changes.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>82</volume>
                <fpage>239</fpage>
                <lpage>59</lpage>
                <pub-id pub-id-type="pmid">1759558</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.breitner.1999.321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Breitner</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyse</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anthony</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welsh-Bohmer</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steffens</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tschanz</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plassman</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skoog</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khachaturian</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>321</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10430421</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.brickell.2006.1307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brickell</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbaugh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.</article-title>
                <source>Arch Neurol</source>
                <volume>63</volume>
                <fpage>1307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16966510</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.campion.1999.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumanchin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belliard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas-Anterion</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbonnier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesnage</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clerget-Darpoux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>664</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10441572</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.check.2002.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Check</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Nerve inflammation halts trial for Alzheimer drug.</article-title>
                <source>Nature</source>
                <volume>415</volume>
                <fpage>462</fpage>
                <pub-id pub-id-type="pmid">11823817</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.cruchaga.2014.550">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cruchaga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karch</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harari</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budde</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertelsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeng</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skorupa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levitch</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryten</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>UK Brain Expression Consortium</collab>
                </person-group>
                <article-title>Hardy J, Ryten M, Trabzuni D, Weale ME, Ramasamy A, Smith C, Sassi C, Bras J, Gibbs JR, Hernandez DG, Lupton MK, Powell J, Forabosco P, Ridge PG, Corcoran CD, Tschanz JT, Norton MC, Munger RG, Schmutz C, Leary M, Demirci FY, Bamne MN, Wang X, Lopez OL, Ganguli M, Medway C, Turton J, Lord J, Braae A, Barber I, Brown K; Alzheimer&#x02019;s Research UK Consortium, Passmore P, Craig D, Johnston J, McGuinness B, Todd S, Heun R, K&#x000f6;lsch H, Kehoe PG, Hooper NM, Vardy ER, Mann DM, Pickering-Brown S, Brown K, Kalsheker N, Lowe J, Morgan K, David Smith A, Wilcock G, Warden D, Holmes C, Pastor P, Lorenzo-Betancor O, Brkanac Z, Scott E, Topol E, Morgan K, Rogaeva E, Singleton AB, Hardy J, Kamboh MI, St George-Hyslop P, Cairns N, Morris JC, Kauwe JS, Goate AM. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</article-title>
                <source>Nature.</source>
                <year>2014</year>
                <volume>505</volume>
                <fpage>550</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24336208</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.cupples.2004.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadovnick</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Relkin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.</article-title>
                <source>Genet Med</source>
                <volume>6</volume>
                <fpage>192</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15266206</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.delaguila.2015.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del-Aguila</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koboldt</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chasse</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruchaga</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Alzheimer's disease: rare variants with large effect sizes.</article-title>
                <source>Curr Opin Genet Dev.</source>
                <year>2015</year>
                <volume>33</volume>
                <fpage>49</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">26311074</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.di_fede.2009.1473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Fede</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catania</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suardi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzoleni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovagnoli</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prioni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erbetta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzoni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francescucci</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spagnoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant&#x000f9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Favero</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagliavini</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.</article-title>
                <source>Science</source>
                <volume>323</volume>
                <fpage>1473</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19286555</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.farrer.1989.485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Sullivan</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Growdon</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Assessment of genetic risk for Alzheimer's disease among first-degree relatives.</article-title>
                <source>Ann Neurol</source>
                <volume>25</volume>
                <fpage>485</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">2774490</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.feldman.2004.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellas</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwam</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastey</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Economic evaluation of donepezil in moderate to severe Alzheimer disease.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>644</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15326236</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.feldman.2007.1056">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>R</given-names>
                  </name>
                  <collab>Study 304 Group</collab>
                </person-group>
                <year>2007</year>
                <article-title>Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2007</year>
                <volume>78</volume>
                <fpage>1056</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17353259</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.ferrer.2004.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boada Rovira</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez Guerra</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rey</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa-Jussa</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.</article-title>
                <source>Brain Pathol</source>
                <volume>14</volume>
                <fpage>11</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">14997933</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.gatz.2006.168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gatz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fratiglioni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortimer</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiske</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>NL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Role of genes and environments for explaining Alzheimer disease.</article-title>
                <source>Arch Gen Psychiatry</source>
                <volume>63</volume>
                <fpage>168</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">16461860</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.godbolt.2004.1743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Godbolt</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cipolotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>1743</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15534185</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.goedert.2006.777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goedert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spillantini</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A century of Alzheimer's disease.</article-title>
                <source>Science</source>
                <volume>314</volume>
                <fpage>777</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">17082447</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.green.2002.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Risk assessment for Alzheimer's disease with genetic susceptibility testing: Has the moment arrived?</article-title>
                <source>Alzheimers Care Q.</source>
                <volume>3</volume>
                <fpage>208</fpage>
                <lpage>14</lpage>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.green.2002.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Go</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benke</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edeki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hipps</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graff-Radford</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Risk of dementia among white and African American relatives of patients with Alzheimer disease.</article-title>
                <source>JAMA</source>
                <volume>287</volume>
                <fpage>329</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">11790212</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.green.2009.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Relkin</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckert</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadovnick</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaid</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook-Deegan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <collab>REVEAL Study Group</collab>
                </person-group>
                <year>2009</year>
                <article-title>Disclosure of APOE genotype for risk of Alzheimer's disease.</article-title>
                <source>N Engl J Med</source>
                <volume>361</volume>
                <fpage>245</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">19605829</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.griciuc.2013.631">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griciuc</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano-Pozo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrado</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesinski</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asselin</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hooli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyman</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanzi</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.</article-title>
                <source>Neuron.</source>
                <volume>78</volume>
                <fpage>631</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">23623698</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.guerreiro.2013.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wojtas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrasquillo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majounie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruchaga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauwe</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hazrati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pocock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lashley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouyel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <collab>Alzheimer Genetic Analysis Group</collab>
                </person-group>
                <article-title>TREM2 Variants in Alzheimer's Disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2013</year>
                <volume>368</volume>
                <fpage>117</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">23150934</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.heston.1981.1085">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heston</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastri</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions.</article-title>
                <source>Arch Gen Psychiatry</source>
                <volume>38</volume>
                <fpage>1085</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">6457579</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.holmes.2008.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boche</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yadegarfar</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullock</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neal</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zotova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoll</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.</article-title>
                <source>Lancet.</source>
                <volume>372</volume>
                <fpage>216</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">18640458</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.international_genomics_of_alzheimers_disease_consortium.2015.658">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>International Genomics of Alzheimer's Disease Consortium</collab>
                </person-group>
                <article-title>Convergent genetic and expression data implicate immunity in Alzheimer's disease.</article-title>
                <source>Alzheimers Dement.</source>
                <year>2015</year>
                <volume>11</volume>
                <fpage>658</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">25533204</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.janssen.2003.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickinson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Early onset familial Alzheimer's disease: Mutation frequency in 31 families.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>235</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12552037</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.jarvik.1996.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jarvik</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goddard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijsman</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.</article-title>
                <source>Am J Hum Genet</source>
                <volume>58</volume>
                <fpage>191</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">8554056</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.jayadev.2008.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jayadev</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kukull</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bid</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease.</article-title>
                <source>Arch Neurol</source>
                <volume>65</volume>
                <fpage>373</fpage>
                <lpage>378</lpage>
                <pub-id pub-id-type="pmid">18332250</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.jonsson.2012.96">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atwal</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snaedal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulem</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gudbjartsson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maloney</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyte</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustafson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhangale</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huttenlocher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsdottir</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f6;nsson</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behrens</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnusson</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorsteinsdottir</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.</article-title>
                <source>Nature.</source>
                <year>2012</year>
                <volume>488</volume>
                <fpage>96</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22801501</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.jonsson.2013.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ph</surname>
                    <given-names>D SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsdottir</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snaedal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huttenlocher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levey</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lah</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rujescu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giegling</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engedal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulstein</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djurovic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibrahim-Verbaas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikram</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorsteinsdottir</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Variant of TREM2 Associated with the risk of Alzheimer's disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2013</year>
                <volume>368</volume>
                <fpage>107</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">23150908</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.khachaturian.2004.518">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khachaturian</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corcoran</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zandi</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breitner</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.</article-title>
                <source>Arch Gen Psychiatry</source>
                <volume>61</volume>
                <fpage>518</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15123497</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.klafki.2006.2840">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klafki</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staufenbiel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornhuber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiltfang</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Therapeutic approaches to Alzheimer's disease.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2840</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">17018549</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.korvatska.2015.920">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korvatska</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayadev</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurtz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbaugh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girirajan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorschner</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiianitsa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brkanac</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garden</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>R47H Variant of TREM2 associated With Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study.</article-title>
                <source>JAMA Neurol</source>
                <year>2015</year>
                <volume>72</volume>
                <fpage>920</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26076170</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.kukull.2002.1737">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kukull</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higdon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowen</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Belle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jolley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Dementia and Alzheimer disease incidence: a prospective cohort study.</article-title>
                <source>Arch Neurol</source>
                <volume>59</volume>
                <fpage>1737</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12433261</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.lai.1999.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kammann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebeck</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nixon</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>331</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10430422</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.larner.2006.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Larner</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doran</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.</article-title>
                <source>J Neurol</source>
                <volume>253</volume>
                <fpage>139</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">16267640</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.leverenz.1998.296">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis.</article-title>
                <source>Exp Neurol</source>
                <volume>150</volume>
                <fpage>296</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">9527899</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.li.2004.1624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higdon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kukull</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Valen Moore</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Belle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowen</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>EB</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>1624</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15534246</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.margallolana.2004.1996">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Margallo-Lana</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrer</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballard</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Influence of the amyloid precursor protein locus on dementia in Down syndrome.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1996</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15184603</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.martins.2005.1888">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oulhaj</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jager</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>1888</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16380608</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.masters.2006.2823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masters</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyreuther</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2823</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">17012295</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.mayeux.1998.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shea</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roses</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyman</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crain</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>MX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phelps</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.</article-title>
                <source>N Engl J Med</source>
                <volume>338</volume>
                <fpage>506</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9468467</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.mega.2005.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mega</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinov</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chow</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reback</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davoodi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connor</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amezcua</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>721</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15883258</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.mckee.2009.709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McKee</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantu</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowinski</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedley-Whyte</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavett</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budson</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santini</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubilus</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>68</volume>
                <fpage>709</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">19535999</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.mintzer.2006.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mintzer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenspan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gharabawi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.</article-title>
                <source>Am J Geriatr Psychiatry</source>
                <volume>14</volume>
                <fpage>280</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">16505133</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.mulnard.2000.1007">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mulnard</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotman</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dyck</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koss</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gamst</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thal</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.</article-title>
                <source>JAMA</source>
                <volume>283</volume>
                <fpage>1007</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">10697060</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.national_institute_on_agingalzheimer_s_association_working_group.1996.1091">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>National Institute on Aging-Alzheimer&#x02019;s Association Working Group</collab>
                </person-group>
                <year>1996</year>
                <article-title>Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer&#x02019;s Association Working Group.</article-title>
                <source>Lancet</source>
                <volume>347</volume>
                <fpage>1091</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8602063</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.national_institute_on_agingreagan_working_group.1997.s1">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>National Institute on Aging-Reagan Working Group</collab>
                </person-group>
                <article-title>Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.</article-title>
                <source>Neurobiol Aging.</source>
                <year>1997</year>
                <month>Jul-Aug</month>
                <volume>18</volume>
                <issue>4</issue>
                <supplement>Suppl</supplement>
                <fpage>S1</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">9330978</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.nochlin.1993.212">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Belle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumi</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.</article-title>
                <source>Alzheimer Dis Assoc Disord</source>
                <volume>7</volume>
                <fpage>212</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">8305189</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.nussbaum.2003.1356">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Alzheimer's disease and Parkinson's disease.</article-title>
                <source>N Engl J Med</source>
                <volume>348</volume>
                <fpage>1356</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12672864</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.overshott.2005.v53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Overshott</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Treatment of dementia.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>76</volume>
                <supplement>Suppl 5</supplement>
                <fpage>v53</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16291922</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.petersen.2005.2379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galasko</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaye</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dyck</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thal</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Vitamin E and donepezil for the treatment of mild cognitive impairment.</article-title>
                <source>N Engl J Med</source>
                <volume>352</volume>
                <fpage>2379</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">15829527</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.popescu.2004.1915">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Popescu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippa</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>JQ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>1915</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15596612</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.prasher.1998.380">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prasher</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kessling</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>West</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Molecular mapping of Alzheimer-type dementia in Down's syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>380</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9506555</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.quaid.2000.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quaid</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hake</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Presymptomatic Genetic Testing with an APP Mutation in Early-Onset Alzheimer Disease: A Descriptive Study of Sibship Dynamics.</article-title>
                <source>J Genet Couns.</source>
                <year>2000</year>
                <month>Aug</month>
                <volume>9</volume>
                <issue>4</issue>
                <fpage>327</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">26141474</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.raskind.2000.2261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>2261</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10881250</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.raux.2005.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raux</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyant-Marechal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>793</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16033913</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.reisberg.2003.1333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reisberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mobius</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Memantine in moderate-to-severe Alzheimer's disease.</article-title>
                <source>N Engl J Med</source>
                <volume>348</volume>
                <fpage>1333</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12672860</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.reisberg.2006.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reisberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doody</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ffler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;bius</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.</article-title>
                <source>Arch Neurol</source>
                <volume>63</volume>
                <fpage>49</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">16401736</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.roberts.2005.250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Relkin</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.</article-title>
                <source>J Geriatr Psychiatry Neurol</source>
                <volume>18</volume>
                <fpage>250</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16306249</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.rogan.2002.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rogan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippa</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Alzheimer's disease and other dementias: a review.</article-title>
                <source>Am J Alzheimers Dis Other Demen</source>
                <volume>17</volume>
                <fpage>11</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11831415</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.romas.2002.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Romas</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciappa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rondon</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estevez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lantigua</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medrano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tycko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.</article-title>
                <source>Arch Neurol</source>
                <volume>59</volume>
                <fpage>87</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11790235</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.rosenberg.2000.2045">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>RN</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>2045</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">10851361</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.roses.2006.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roses</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Perspective on a pathogenesis and treatment of Alzheimer's disease.</article-title>
                <source>Alzheimers Dement.</source>
                <volume>2</volume>
                <fpage>59</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19595857</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.schenk.1999.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schenk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbour</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grajeda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guido</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson-Wood</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kholodenko</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lieberburg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soriano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shopp</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasquez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandevert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wogulis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yednock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Games</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seubert</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.</article-title>
                <source>Nature</source>
                <volume>400</volume>
                <fpage>173</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10408445</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.schupf.2001.979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schupf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nightingale</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohlenhoff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bewley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayeux</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Specificity of the fivefold increase in AD in mothers of adults with Down syndrome.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>979</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">11571320</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.seltzer.2004.1852">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seltzer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zolnouni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ieni</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>1852</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15596605</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.silverman.1994.577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silverman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaccario</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmeidler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Patterns of risk in first-degree relatives of patients with Alzheimer's disease.</article-title>
                <source>Arch Gen Psychiatry</source>
                <volume>51</volume>
                <fpage>577</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">8031231</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.sleegers.2001.197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sleegers</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Alzheimer's Disease: Genes, Pathogenesis and Risk Prediction.</article-title>
                <source>Community Genet</source>
                <volume>4</volume>
                <fpage>197</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">12107347</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.snider.2009.638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Snider</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holtzman</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.</article-title>
                <source>Arch Neurol</source>
                <volume>66</volume>
                <fpage>638</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">19433664</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.steinbart.2001.1828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steinbart</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorkaj</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.</article-title>
                <source>Arch Neurol</source>
                <volume>58</volume>
                <fpage>1828</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11708991</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.tariot.2004.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tariot</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossberg</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gergel</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.</article-title>
                <source>JAMA</source>
                <volume>291</volume>
                <fpage>317</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">14734594</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.tariot.2000.2269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tariot</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kershaw</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilienfeld</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>2269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">10881251</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.teri.2000.1271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logsdon</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tractenberg</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tariot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellow</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auchus</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schafer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thal</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <collab>Alzheimer's Disease Cooperative Study</collab>
                </person-group>
                <year>2000</year>
                <article-title>Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1271</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11087767</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.towner.2002.1038">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Towner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loewy</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Ethics of preimplantation diagnosis for a woman destined to develop early-onset Alzheimer disease.</article-title>
                <source>JAMA</source>
                <volume>287</volume>
                <fpage>1038</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11866654</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.tsuang.1999.1489">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCormick</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nochlin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverenz</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peskind</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirra</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gearing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberg</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kukull</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.</article-title>
                <source>Arch Neurol</source>
                <volume>56</volume>
                <fpage>1489</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">10593304</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.van_cauwenberghe.2015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Cauwenberghe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sleegers</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>The genetic landscape of Alzheimer disease: clinical implications and perspectives.</article-title>
                <source>Genet Med.</source>
                <year>2015</year>
                <month>Aug</month>
                <day>27</day>
                <comment>Epub ahead of print</comment>
                <pub-id pub-id-type="pmid">26312828</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.van_der_cammen.2004.2110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Cammen</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croes</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dermaut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jager</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease.</article-title>
                <source>J Am Geriatr Soc</source>
                <volume>52</volume>
                <fpage>2110</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15571552</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.verlinsky.2002.1018">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verlinsky</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechitsky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verlinsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masciangelo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lederer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuliev</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation.</article-title>
                <source>JAMA</source>
                <volume>287</volume>
                <fpage>1018</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11866650</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.wang.2000.2061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>SQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>HC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>2061</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10851363</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.wolozin.2000.1439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolozin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruosseau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celesia</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors.</article-title>
                <source>Arch Neurol</source>
                <volume>57</volume>
                <fpage>1439</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11030795</pub-id>
              </element-citation>
            </ref>
            <ref id="alzheimer.REF.yaffe.2004.1705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yaffe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemons</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McBee</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindblad</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>1705</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15534261</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="alzheimer.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="alzheimer.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>24 September 2015 (tb) Revision: revisions to late-onset familial AD; citations added</p>
            </list-item>
            <list-item>
              <p>3 April 2014 (tb) Revision: <italic toggle="yes">PLD3</italic> included [<xref ref-type="bibr" rid="alzheimer.REF.cruchaga.2014.550">Cruchaga et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>30 January 2014 (tb) Revision: addition of information about new AD susceptibility loci</p>
            </list-item>
            <list-item>
              <p>3 July 2013 (tb) Revision: <italic toggle="yes">CD33</italic> included [<xref ref-type="bibr" rid="alzheimer.REF.griciuc.2013.631">Griciuc et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>13 December 2012 (tb) Revision: p.Arg47His allelic variant in <italic toggle="yes">TREM2</italic> found to be a risk factor for late-onset AD [Guerreiro et al 2012, Jonsson et al 2012b]</p>
            </list-item>
            <list-item>
              <p>2 August 2012 (tb) Revision: addition of information about <italic toggle="yes">APP</italic> mutation p.Ala673Thr</p>
            </list-item>
            <list-item>
              <p>30 March 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>24 July 2008 (cd) Revision: single-nucleotide polymorphism (SNP) in <italic toggle="yes">CALHM1</italic> associated with increased risk for late-onset AD.</p>
            </list-item>
            <list-item>
              <p>13 June 2007 (tb) Revision: sequence analysis for <italic toggle="yes">APP</italic> available on a clinical basis; new gene identified for late-onset familial AD</p>
            </list-item>
            <list-item>
              <p>9 May 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 February 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>22 December 2003 (tb) Author revisions</p>
            </list-item>
            <list-item>
              <p>12 September 2003 (tb) Revision: clinical testing available for <italic toggle="yes">APP</italic></p>
            </list-item>
            <list-item>
              <p>29 January 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>22 June 2001 (tb) Author revisions</p>
            </list-item>
            <list-item>
              <p>24 September 1999 (tb) Author revisions</p>
            </list-item>
            <list-item>
              <p>31 August 1999 (tb) Author revisions</p>
            </list-item>
            <list-item>
              <p>23 October 1998 (me) Overview posted to live Web site</p>
            </list-item>
            <list-item>
              <p>Spring 1996 (tb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
